Changeflow GovPing Pharma & Healthcare Therapeutic Touch and Acupressure on Depressive...
Routine Notice Added Final

Therapeutic Touch and Acupressure on Depressive Symptoms (NCT07532512)

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH ClinicalTrials.gov registered a new study (NCT07532512) investigating therapeutic touch and acupressure as interventions for mild-to-moderate depressive symptoms. The randomized controlled trial will enroll participants receiving either eight therapeutic touch sessions or eight acupressure sessions over four weeks. Acupressure points include Yintang (EX-HN3), Shenmen (HT7), and Neiguan (PC6).

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

A new clinical trial registration has been added to ClinicalTrials.gov documenting a randomized controlled study comparing therapeutic touch intervention and acupressure intervention for participants with mild-to-moderate depressive symptoms. The therapeutic touch protocol involves an 8-session program over four weeks with a centering phase, energy field assessment, and energy balancing. The acupressure protocol uses three specific points (Yintang, Shenmen, Neiguan) applied for two minutes each per session.

Researchers and healthcare providers offering integrative or complementary medicine services should be aware of this trial as it may generate evidence relevant to non-pharmacological approaches for managing depression. The study provides no immediate compliance obligations but contributes to the growing body of clinical research on alternative therapeutic modalities for mental health conditions.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Therapeutic Touch and Acupressure on Depressive Symptoms

N/A NCT07532512 Kind: NA Apr 16, 2026

Abstract

Therapeutic touch intervention Participants in the therapeutic touch group received eight sessions over four weeks (two sessions per week), with each session lasting approximately 20 minutes. The intervention was conducted by a researcher trained in therapeutic touch following a standardized protocol.

The session began with a centering phase lasting approximately 2-3 minutes, during which the practitioner focused attention through controlled breathing and mental concentration. This was followed by an energy field assessment lasting approximately 5-7 minutes, during which the practitioner held the hands 5-10 cm above the body without direct contact and slowly moved from the head toward the feet to assess the energy field. The final phase consisted of energy balancing lasting approximately 10-12 minutes, during which slow and rhythmic hand movements were used to promote balance in the participant's energy field. Acupressure intervention Participants in the acupressure group also received eight sessions over four weeks (two sessions per week). During each session, pressure was applied to three acupressure points for two minutes each, resulting in a total active stimulation time of six minutes. Including short preparation and resting periods before and after the intervention, the total session duration was approximately ten minutes. The acupressure points used in this study were Yintang (EX-HN3), Shenmen (HT7), and Neiguan (PC6). Yintang is located on the midline between the ...

Conditions: Depressive Symptoms Mild to Moderate in Severity

Interventions: Therapeutic touch intervention, Acupressure intervention

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07532512

Who this affects

Applies to
Healthcare providers Patients Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial participation Complementary therapy delivery Mental health intervention
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!